ClinicalTrialsFinder
RecruitingNot ApplicableNCT04855825

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Sponsor

Kessler Foundation

Enrollment

10 participants

Start Date

Oct 5, 2017

Study Type

INTERVENTIONAL

Conditions

Cognitive ImpairmentMultiple SclerosisGait Disorders, NeurologicMotility Disorder

Summary

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether using a wearable robotic exoskeleton — a powered suit that supports walking — can improve both mobility and thinking abilities in people with multiple sclerosis (MS). **You may be eligible if...** - You have been diagnosed with multiple sclerosis - You have moderate to severe walking difficulty but can still walk with the exoskeleton's assistance - You have some difficulty with thinking or problem-solving - You are between 18 and 75 years old - You have not had an MS flare-up in at least one month **You may NOT be eligible if...** - You are unable to walk even with robotic assistance - You have had a recent MS flare-up within the past month Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERobotic Exoskeleton Rehabilitation

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

OTHERConventional Gait Therapy

Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Locations(1)

Kessler Foundation

West Orange, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04855825

Related Trials

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

NCT027842101 location

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT000012481 location

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

NCT058494671 location

Feasibility of Web-based Therapy Sessions

NCT075606961 location